Selected article for: "bronchoalveolar lavage and ground glass opacity"
Author: Kim, Se Yong; Kim, Se Jin; Yoon, Doran; Hong, Seung Wook; Park, Sehhoon; Ock, Chan-Young
Title: A Case of Statin-Induced Interstitial Pneumonitis due to Rosuvastatin
  • Cord-id: o4uj3l8r
  • Document date: 2015_6_30
    • ID: o4uj3l8r
    Snippet: Statins lower the hyperlipidemia and reduce the incidence of cardiovascular events and related mortality. A 60-year-old man who was diagnosed with a transient ischemic attack was started on acetyl-L-carnitine, cilostazol, and rosuvastatin. After rosuvastatin treatment for 4 weeks, the patient presented with sudden onset fever, cough, and dyspnea. His symptoms were aggravated despite empirical antibiotic treatment. All infectious pathogens were excluded based on results of culture and polymerase
    Document: Statins lower the hyperlipidemia and reduce the incidence of cardiovascular events and related mortality. A 60-year-old man who was diagnosed with a transient ischemic attack was started on acetyl-L-carnitine, cilostazol, and rosuvastatin. After rosuvastatin treatment for 4 weeks, the patient presented with sudden onset fever, cough, and dyspnea. His symptoms were aggravated despite empirical antibiotic treatment. All infectious pathogens were excluded based on results of culture and polymerase chain reaction of the bronchoscopic wash specimens. Chest radiography showed diffuse ground-glass opacities in both lungs, along with several subpleural ground-glass opacity nodules; and a foamy alveolar macrophage appearance was confirmed on bronchoalveolar lavage. We suspected rosuvastatin-induced lung injury, discontinued rosuvastatin and initiated prednisolone 1 mg/kg tapered over 2weeks. After initiating steroid therapy, his symptoms and radiologic findings significantly improved. We suggest that clinicians should be aware of the potential for rosuvastatin-induced lung injury.

    Search related documents:
    Co phrase search for related documents
    • local clinic and low density: 1
    • local clinic and low density lipoprotein: 1
    • local clinic and lung injury: 1, 2
    • low density and lung disease: 1, 2, 3, 4, 5, 6
    • low density and lung field: 1
    • low density and lung injury: 1, 2, 3, 4, 5
    • low density and macrophage appearance: 1
    • low density lipoprotein and lung disease: 1
    • low density lipoprotein and lung injury: 1
    • low density lipoprotein and macrophage appearance: 1
    • low frequency and lung disease: 1, 2, 3, 4
    • lung biopsy and lymphocytic alveolitis: 1, 2